Melasma Treatment in Montana (Facial Hyperpigmentation)

Montana adult care by secure video visit, self pay option starting at $49, MD-only, insurance is not required.

Melasma is a common chronic skin condition causing brown to gray-brown patches on the face, most often on the cheeks, forehead, upper lip, nose bridge, and chin. It predominantly affects women and is especially common in people with Fitzpatrick skin types III through V — though it can affect anyone. The good news is that melasma is highly visual by nature, making telehealth an effective platform for assessment and treatment planning. During a video visit, the MD reviews your pigmentation pattern, distribution, and history of triggers such as sun exposure, hormonal factors, and medications, then develops a treatment plan based on current evidence. Mild to moderate melasma is well-suited for telehealth management with topical lightening agents and comprehensive sun protection counseling. Presentations that are atypical, rapidly changing, or potentially suspicious for another diagnosis are directed to in-person evaluation. This page is for adults located in Montana, including Billings, Missoula, Great Falls, Bozeman, Butte, Helena, Kalispell, Havre, Anaconda, and surrounding areas.

Quick navigation:

Eligibility checklist
Decision guide
Treatment options
FAQs
References

Self pay option starting at $49
MD-only care (no mid-levels)
Insurance is not required
Licensed telehealth care for patients located in Montana at the time of the visit

Book a Visit Explore Montana Pages View All Adult Conditions

Last reviewed on 2026-03-23 by Parth Bhavsar, MD

ICD-10 commonly used: L81.1 (final coding depends on clinical details)

Online MD-Only Melasma Care in Montana

Visual assessment of hyperpigmentation pattern and distribution via video
Guideline-based treatment plans including topical lightening agents and sun protection counseling
Prescriptions for hydroquinone, tretinoin, azelaic acid, or triple combination cream when appropriate
Hormonal factor discussion and referral guidance when needed

Adults 18+ only. TeleDirectMD is not an emergency service. Seek urgent in-person evaluation immediately for any pigmented lesion that is rapidly changing, has irregular borders, is raised or nodular, bleeds spontaneously, or has features that may suggest melanoma. TeleDirectMD does not prescribe controlled substances.

Melasma Telehealth Eligibility Checklist for Montana

You are likely eligible for a TeleDirectMD video visit if ALL of these are true:

✓ You Are Eligible If

You are 18 years old or older
You are physically located in Montana at the time of the visit
You have brown to gray-brown patches on sun-exposed areas of your face that you would like evaluated
Your pigmentation has been present for weeks to months and is stable or slowly worsening (not rapidly changing)
You can show your skin to the MD during the video visit for visual assessment
You do not have raised, nodular, or irregularly bordered lesions that could suggest melanoma or another condition requiring biopsy
Insurance is not required. A self pay option is available.

✗ You Are Not Eligible If

You are under 18 years old
You have a pigmented lesion that is rapidly changing in size, color, or shape — this requires urgent in-person evaluation
You have a raised, nodular, or bleeding pigmented lesion that may need biopsy to rule out melanoma
You have symptoms suggesting a systemic cause of pigmentation such as Addison's disease (fatigue, weight loss, salt craving, diffuse darkening)
You need procedural treatment such as chemical peels, laser therapy, or microneedling — these require in-person dermatology
You are pregnant and need a new melasma treatment regimen (many topical agents have limited safety data in pregnancy and require in-person counseling)

If you have a rapidly changing, raised, or suspicious pigmented lesion, seek urgent in-person evaluation or emergency care. TeleDirectMD is not an emergency service and does not perform or arrange biopsies.

How Online Melasma Treatment Works in Montana

Book your video visit and prepare key details

Insurance is not required. No referral needed. Many visits are available same day, depending on scheduling. Before your visit, note how long you have had the pigmentation, which areas of your face are affected, whether it worsens with sun exposure, any hormonal changes such as pregnancy or starting or stopping oral contraceptives, medications you take, your skin care routine and any lightening products you have tried, and any family history of melasma.

See a Montana licensed MD by video

The MD performs a visual assessment of your pigmentation pattern, distribution, and clinical features via video. This includes evaluating the location and symmetry of patches, reviewing your trigger history including sun exposure and hormonal factors, assessing your prior treatment history and skin sensitivity, and screening for any features that might suggest a diagnosis other than melasma that would require in-person evaluation.

Get a treatment plan and, if appropriate, a prescription

If medication is clinically appropriate, we send an e-prescription to common Montana pharmacies such as CVS Pharmacy, Walgreens, Walmart Pharmacy, Albertsons Pharmacy, Costco Pharmacy. You receive a comprehensive treatment plan including topical lightening agents when appropriate, detailed sun protection guidance, realistic expectations for the timeline of improvement (typically 8 to 24 weeks), instructions for managing side effects, and clear guidance on when to follow up or seek in-person dermatology care.

Book a Visit

Montana Telehealth Regulations for Online Melasma Care

Montana Code Annotated 37-3-102 recognizes telemedicine as a legitimate practice of medicine and permits licensed providers to deliver healthcare services through telecommunications technologies. The Montana Board of Medical Examiners requires that telehealth encounters meet the same standard of care as in-person visits, including appropriate documentation and prescribing practices.

Location matters: you must be physically in Montana during the visit. Insurance is not required. TeleDirectMD does not prescribe controlled substances.

TeleDirectMD vs Other Care Options for Melasma in Montana

Here is how TeleDirectMD compares to common settings for adult melasma care in Montana:

Care option	Typical cost	Wait time	Provider type	Best for
TeleDirectMD	Self pay option starting at $49	Same day, often within hours	Board-certified MD only (no mid-levels)	Mild to moderate melasma with visual assessment, guideline-based topical prescriptions, sun protection counseling, and clear referral criteria
Primary Care	$100 to $350+ (varies)	Days to weeks	MD or DO	Melasma with suspected systemic cause, combined visit with other health concerns, or initial evaluation before referral
Dermatology	$150 to $400+ (varies)	Weeks to months (varies)	Dermatologist MD or DO	Refractory melasma, procedural treatments such as chemical peels or laser therapy, atypical presentations requiring biopsy, or severe or treatment-resistant cases
Urgent Care	$150 to $300+ (before insurance)	1 to 3 hours typical	MD, DO, PA, or NP	Not the typical setting for melasma; appropriate if a suspicious or rapidly changing pigmented lesion needs urgent same-day evaluation before dermatology referral

Bottom line: TeleDirectMD is a strong fit for adults with typical melasma who need prescription topical therapy, structured sun protection guidance, and clear next steps — without long dermatology wait times.

Should I Use TeleDirectMD for Melasma in Montana? Decision Guide

Do you have any urgent or concerning features?

A pigmented lesion that is rapidly changing in size, color, shape, or border
A raised, nodular, or thickened pigmented area (melasma is always flat)
A lesion that bleeds spontaneously or does not heal
New diffuse darkening of the skin with fatigue, weight loss, or salt cravings (possible Addison's disease)
Pigmentation with associated systemic symptoms that suggest an underlying medical condition

If yes, seek urgent in-person evaluation — these features require a clinician to examine the skin directly and may require biopsy or laboratory workup

If no, continue to Step 2

Are you 18+ and currently in Montana?

If yes, continue to Step 3

If no, use in-person care as appropriate

Does your pigmentation pattern fit typical melasma?

Flat brown to gray-brown patches on the face (cheeks, forehead, upper lip, nose, or chin)
Symmetric distribution on both sides of the face
Gradual onset or worsening with sun exposure, pregnancy, or hormonal contraceptive use
Stable or slowly changing (not rapidly evolving over days)

If yes, continue to Step 4

If no or you are unsure about your skin condition, in-person evaluation is often preferred

You are likely appropriate for a TeleDirectMD video visit

TeleDirectMD can assess your melasma via visual review during the video visit, evaluate your trigger history including hormonal factors and sun exposure, prescribe guideline-based topical lightening agents when appropriate, provide comprehensive sun protection counseling, and give you realistic expectations for improvement. If your presentation is atypical or requires procedural treatment, we will direct you to in-person dermatology care.

Book a Visit

What Does Melasma Treatment Cost in Montana?

Transparent options. Insurance is not required.

TeleDirectMD Video Visit

$49

Self pay option. Insurance is not required.

MD evaluation with visual assessment of hyperpigmentation pattern
Trigger review including sun exposure, hormonal factors, and medication history
Prescription for topical lightening agents when clinically appropriate
Comprehensive sun protection and skin care counseling
Realistic timeline for improvement and side effect guidance
Clear follow-up steps and dermatology referral criteria

Typical Cost Comparison

Common ranges people see before insurance. Actual costs vary.

TeleDirectMD$49

Primary Care$100 to $350+

Dermatology$150 to $400+

Emergency Room$500 to $3,000+

Prescription costs at your pharmacy are separate and vary by medication and pharmacy.

No hidden fees. If medication is not clinically appropriate, you still receive a complete evaluation, guidance, and clear instructions on what level of care you need next.

What Is Melasma?

Melasma is a common acquired disorder of skin hyperpigmentation characterized by symmetric, brown to gray-brown macules and patches that predominantly affect sun-exposed areas of the face. The most commonly involved areas are the cheeks, forehead, upper lip, nose bridge, and chin — a distribution sometimes called the 'mask of pregnancy.' Melasma develops when melanocytes (pigment-producing cells) are overstimulated and produce excess melanin, which accumulates in the epidermis, the dermis, or both. The condition is chronic and relapsing, meaning that even after successful treatment, recurrence is common — particularly with sun exposure or hormonal changes.

Melasma affects up to 5 million Americans and occurs worldwide, though it is most prevalent in individuals with Fitzpatrick skin types III through V and in populations from regions with high ultraviolet radiation exposure. Women are far more commonly affected than men. Key triggers include ultraviolet and visible light exposure (the most important factor), hormonal influences such as pregnancy, oral contraceptives, and hormone replacement therapy, and genetic predisposition — over 60 percent of patients report a family member with the same condition. Melasma associated with pregnancy often fades postpartum, but melasma from other causes tends to be persistent and requires ongoing management. Because melasma is a chronic condition, realistic expectations are essential: treatment focuses on long-term control rather than a permanent cure.

TeleDirectMD focuses on typical melasma in adults where the diagnosis is clinically consistent based on the visual appearance, distribution, and trigger history. The visual nature of melasma makes telehealth an effective platform for evaluation, treatment planning, and medication prescribing. Presentations that are atypical, rapidly changing, raised, or otherwise concerning for another condition are directed to in-person evaluation. TeleDirectMD does not perform biopsies, provide procedural treatments such as chemical peels or laser, or manage melasma requiring dermatology-level procedural care.

Causes and Risk Factors

Melasma is multifactorial, arising from the interaction of environmental triggers, hormonal influences, and genetic susceptibility. Understanding the specific triggers in each patient guides treatment selection and prevention counseling.

UV and visible light exposure: ultraviolet and visible light are the most important triggers for melasma. Sun exposure directly stimulates melanocyte activity and melanin production, which is why melasma predominantly appears on sun-exposed facial areas and worsens in summer months. Visible light, including high-energy visible (HEV or 'blue light') from screens, can also worsen melasma, particularly in individuals with darker skin types — making broad-spectrum, iron-oxide-containing sunscreens especially important.
Hormonal factors: estrogen and progesterone play a significant role in melasma. Pregnancy is one of the most common triggers (hence the term 'mask of pregnancy'), with melasma occurring in 10 to 15 percent of pregnant women. Oral contraceptive pills and other hormonal contraceptives (patches, implants, IUDs) trigger or worsen melasma in 10 to 25 percent of users. Hormone replacement therapy is another common hormonal trigger. Thyroid disorders have also been associated with melasma in some studies.
Genetic predisposition: family history is a strong risk factor for melasma. Studies show that over 40 to 60 percent of patients with melasma report having affected first-degree relatives. Genetic factors influence both melanocyte sensitivity to UV light and hormonal stimulation, contributing to the skin types most predisposed to melasma.
Fitzpatrick skin types III through V: melasma disproportionately affects individuals with moderate to dark baseline skin pigmentation (Fitzpatrick types III through V), including those of Hispanic, Latin American, Middle Eastern, South Asian, Southeast Asian, and African descent. These skin types have more reactive melanocytes that produce more pigment in response to UV exposure and hormonal signals. People with very fair or very dark skin types are less commonly affected.
Medications and photosensitizing substances: certain medications can trigger or worsen melasma, including some anticonvulsants, targeted cancer therapies, and photosensitizing drugs. Scented cosmetics, perfumed soaps, and toiletries can cause phototoxic reactions that trigger melasma-like hyperpigmentation. A thorough medication and skin care review is part of the evaluation.
Skin inflammation and procedures: any source of skin irritation, inflammation, or injury — including aggressive skin care routines, harsh chemical peels, or laser treatments — can trigger post-inflammatory hyperpigmentation and worsen melasma, particularly in darker skin types. This is why melasma management must proceed cautiously and why some procedural treatments carry significant risk of worsening in susceptible individuals.

Not every facial pigmentation is melasma. Post-inflammatory hyperpigmentation, solar lentigines, drug-induced pigmentation, and less common conditions can appear similar. TeleDirectMD uses visual assessment of the pattern, distribution, and clinical history to distinguish typical melasma from conditions that may require in-person evaluation or biopsy.

Symptoms and Red Flags for Melasma in Montana

Use this table to understand which melasma presentations are appropriate for telehealth and which may need in-person evaluation.

Symptom or situation	What it suggests	Telehealth appropriate?	Red flag requiring in-person care
Flat brown to gray-brown patches on the cheeks, forehead, upper lip, or nose bridge, symmetric on both sides	Classic epidermal or mixed melasma	Yes	If distribution is atypical or lesions are not flat
Melasma that worsens with sun exposure or during summer months	UV-triggered melasma flare	Yes	Rarely a red flag; counsel on sun protection
New or worsening melasma after starting oral contraceptives or hormone replacement therapy	Hormone-triggered melasma	Yes	Discuss hormonal trigger management; may suggest discontinuing OCP if appropriate
Melasma during or after pregnancy that has not faded	Persistent post-partum melasma	Yes — if postpartum and not breastfeeding with treatment options	If breastfeeding, many topical agents are not recommended; in-person counseling preferred
Pigmented patch that is raised, nodular, or thickened	Not consistent with melasma — melasma is always flat; may suggest another condition	No	Requires urgent in-person evaluation; raised pigmented lesion may need biopsy to rule out melanoma or other diagnosis
Rapidly changing pigmented lesion — new growth, changing border, or color change over days to weeks	Concerning for melanoma or other serious condition	No	Seek urgent in-person evaluation immediately — do not delay
Diffuse darkening of skin with fatigue, weight loss, salt cravings, and low blood pressure	Possible Addison's disease (adrenal insufficiency)	No	Seek urgent in-person evaluation with laboratory workup — this is a systemic medical emergency
Pigmented patches following prior skin trauma, inflammation, or acne in predictable locations	Post-inflammatory hyperpigmentation rather than melasma	Sometimes — can overlap with management approach	If uncertain or not responding to treatment, in-person evaluation is preferred

Differential Diagnosis: Melasma vs Other Conditions

Several conditions can cause facial hyperpigmentation that resembles melasma. Accurate diagnosis matters because treatment approaches differ. TeleDirectMD uses the pigmentation pattern, distribution, symmetry, associated features, and clinical history to evaluate for typical melasma and to direct atypical presentations to in-person care.

Sometimes Appropriate for Telehealth Guidance

Classic melasma with symmetric flat brown patches on sun-exposed facial areas and a consistent trigger history
Post-inflammatory hyperpigmentation (PIH) from prior acne, eczema, or skin trauma — distribution often asymmetric and follows prior skin injury sites
Melasma worsened by hormonal contraception where trigger modification can be discussed
Melasma that has responded partially to prior treatment and needs prescription adjustment or maintenance planning
Evaluation of typical sun-induced facial discoloration with clear clinical history consistent with melasma

Often Requires In-Person Evaluation

Any raised, nodular, or thickened pigmented lesion — melasma is always flat; raised lesions may require biopsy to rule out melanoma or other skin cancers
Rapidly evolving or rapidly changing pigmented lesion (change in size, color, shape, or border over days to weeks)
Pigmentation with irregular, notched, or asymmetric borders suggestive of lentigo maligna or early melanoma
Drug-induced hyperpigmentation requiring medication review and potentially dermatology input
Suspected Addison's disease or other systemic cause of hyperpigmentation with associated systemic symptoms
Refractory melasma or atypical presentations needing procedural treatment (chemical peels, laser, microneedling) or Wood lamp/dermoscopic evaluation

Melasma vs Post-Inflammatory Hyperpigmentation (PIH)

Melasma presents as symmetric, bilateral patches on sun-exposed facial areas often triggered by UV light or hormones, with no preceding skin injury. Post-inflammatory hyperpigmentation develops at the exact sites of prior skin inflammation or injury — acne, eczema, cuts, or procedures — and is typically more asymmetric. Both conditions are flat and can coexist, particularly in patients with acne-prone skin. Management has some overlap (sunscreen, topical lightening agents) but addressing the underlying inflammatory trigger is critical for PIH.

Melasma vs Solar Lentigines (Age Spots)

Solar lentigines are discrete, well-circumscribed round or oval brown macules resulting from localized proliferation of melanocytes from chronic UV exposure. They tend to appear as individual spots rather than the confluent, symmetric patches of melasma. Solar lentigines are more common on the backs of hands, forearms, and face and are typically more uniformly shaped and more sharply demarcated than melasma patches. Both can appear on sun-exposed areas of the face, and distinguishing them informs treatment planning.

Melasma vs Drug-Induced Hyperpigmentation

Certain medications — including antimalarials, amiodarone, minocycline, some chemotherapeutic agents, and heavy metals — can cause generalized or patterned hyperpigmentation that may resemble melasma. The distribution may be diffuse, involve mucous membranes, or follow a pattern specific to the drug. A thorough medication history is essential when evaluating facial hyperpigmentation, and drug-induced pigmentation may require medication discontinuation and dermatology input.

If your pigmentation does not match typical melasma — particularly if it is raised, rapidly changing, irregular, or accompanied by systemic symptoms — TeleDirectMD will direct you to in-person evaluation. Patient safety is the top priority, and we are direct about the limits of telehealth for pigmentation assessment.

When Is a Video Visit Appropriate?

When a Video Visit Is Appropriate

Flat brown to gray-brown patches on sun-exposed facial areas consistent with melasma
Ability to show the affected skin during the video visit for visual assessment
Melasma that has been present for weeks to months and is stable or slowly worsening
Interested in starting or adjusting prescription topical lightening treatment
Seeking sun protection counseling and a structured treatment plan
Prior treatments that have not been effective and need a different approach
Located in Montana at time of visit

Situations Requiring In-Person or Specialist Care

Any raised, nodular, or thickened pigmented lesion — melasma is always flat
Rapidly changing pigmented lesion: change in size, color, shape, or border over days to weeks
Lesion with irregular, notched, or asymmetric borders that may suggest melanoma
Pigmented lesion that bleeds spontaneously, crusts, or does not heal
Diffuse skin darkening with systemic symptoms suggesting Addison's disease or another systemic condition
Refractory or severe melasma requiring procedural dermatologic treatment
Pregnancy with need for new melasma treatment (limited safe options require in-person counseling)

If any red-flag features are present, seek urgent in-person evaluation. TeleDirectMD is not an emergency service and does not perform biopsies or procedural treatments.

Treatment Options

Melasma treatment requires a combination approach that includes strict photoprotection as the foundation, topical lightening agents targeting melanin production, and — when appropriate — systemic adjuncts. Current evidence supports the use of hydroquinone, tretinoin, azelaic acid, and triple combination cream as first-line topical options, with oral tranexamic acid as an emerging evidence-based adjunct for moderate to severe or refractory cases. Treatment typically requires 8 to 24 weeks to show meaningful improvement, and recurrence is common without ongoing sun protection and maintenance therapy.

Photoprotection — the essential foundation

Strict, consistent sun protection is the single most important component of melasma management and is required for any topical treatment to be effective. This includes applying a broad-spectrum sunscreen with SPF 50 or higher every morning (and reapplying every 2 hours outdoors), preferably one containing zinc oxide, titanium dioxide, and iron oxide to block both UV and visible light. A wide-brimmed hat and seeking shade are also recommended. Without aggressive photoprotection, topical lightening agents are significantly less effective and recurrence is rapid.

Topical lightening agents

Hydroquinone 4% cream is the most widely used and evidence-supported topical agent for melasma. It works by inhibiting tyrosinase, the key enzyme in melanin production. Hydroquinone is typically used for 8 to 12 weeks at a time (cyclical use) with breaks to reduce the risk of ochronosis with prolonged use. Tretinoin 0.025 to 0.05% cream enhances the penetration and efficacy of hydroquinone, accelerates keratinocyte turnover, and inhibits melanin transfer — making it an important partner in melasma therapy. Azelaic acid 15 to 20% is an effective alternative or adjunct that inhibits tyrosinase, reduces abnormal melanocyte activity, and has anti-inflammatory properties — making it particularly useful in patients with sensitive skin or who cannot tolerate hydroquinone. Triple combination cream (hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%, marketed as Tri-Luma) is FDA-approved for melasma and is among the most effective topical options, with studies showing 77% of patients achieving near-complete clearing.

Oral tranexamic acid (emerging adjunct)

Oral tranexamic acid 250 mg twice daily is an emerging evidence-based adjunct for moderate to severe or refractory melasma. Tranexamic acid is an anti-fibrinolytic agent that reduces melanocyte stimulation by blocking the plasminogen-to-plasmin pathway and decreasing prostaglandins, endothelin-1, and VEGF — all of which drive melanogenesis and dermal vascularization in melasma. Multiple clinical studies and a systematic review demonstrate meaningful MASI score reductions, with oral TXA typically used for 8 to 12 weeks alongside topical therapy and sunscreen. Before prescribing, the MD will review relevant medical history including personal or family history of blood clots, as TXA is not appropriate for patients with thrombotic risk factors. Females on combination hormonal contraception should not be treated with oral TXA due to additive thrombotic risk.

Hormonal trigger management

When melasma is triggered or worsened by oral contraceptive pills, hormone replacement therapy, or other hormonal agents, discussing whether to modify or discontinue the offending agent is an important part of the management conversation. Pregnancy-induced melasma often fades naturally in the months after delivery, and treatment is typically deferred to allow spontaneous improvement. The MD will review your hormonal history and help guide these decisions as part of the treatment plan.

What TeleDirectMD Does Not Manage

Raised, nodular, or rapidly changing pigmented lesions that may need biopsy to rule out melanoma
Procedural treatments for melasma including chemical peels, laser therapy, intense pulsed light, or microneedling
Refractory melasma requiring in-person dermatology evaluation and procedural management
Melasma in pregnancy where medication options are significantly restricted and require in-person counseling
Evaluation requiring Wood lamp examination, dermoscopy, or skin biopsy to differentiate melasma from other pigmentary conditions

Common Medication Options

These are common examples based on melasma type and severity. The actual medication, combination, dose, and duration are determined by the MD after reviewing your pigmentation pattern, skin type, prior treatments, sensitivity, allergies, hormonal history, and relevant medical history.

Medication	Typical use	Category	Key considerations
Hydroquinone 4% cream	Apply a thin layer to affected patches nightly; use cyclically (8 to 12 weeks on, then a break)	Topical depigmenting agent (tyrosinase inhibitor)	Gold standard first-line topical for melasma. Requires prescription (no longer available OTC). Use cyclically to reduce the small risk of ochronosis with prolonged continuous use. Always combine with sunscreen. Mild irritation is common initially. Avoid during pregnancy.
Tretinoin 0.025 to 0.05% cream	Apply a small amount to affected areas nightly, starting 2 to 3 times per week and increasing as tolerated	Topical retinoid	Enhances hydroquinone penetration and efficacy, accelerates keratinocyte turnover, and inhibits melanin transfer. Commonly used in combination with hydroquinone. Expect skin irritation, dryness, and sun sensitivity — always use sunscreen. Minimum 24 weeks for full effect. Not for use in pregnancy.
Triple combination cream (Tri-Luma: hydroquinone 4% / tretinoin 0.05% / fluocinolone acetonide 0.01%)	Apply a thin film to affected facial areas once nightly for up to 8 weeks per course	Combination topical (depigmenting + retinoid + low-potency corticosteroid)	FDA-approved for melasma. Most effective topical option in clinical trials, with 77% of patients achieving near-complete clearing. The corticosteroid component reduces irritation and inflammation. Not for long-term continuous use due to corticosteroid risks; use in cyclical courses. Not for use in pregnancy.
Azelaic acid 15 to 20% gel or cream	Apply twice daily to affected areas	Topical depigmenting agent (tyrosinase inhibitor + anti-inflammatory)	Effective alternative or adjunct for patients who cannot tolerate hydroquinone or retinoids. Also helps with post-inflammatory hyperpigmentation. Better tolerated in darker skin types. Mild burning or stinging common initially. Generally considered safe in pregnancy (discuss with MD). Available in 15% (Finacea) by prescription.
Oral tranexamic acid 250 mg twice daily	Take by mouth twice daily, typically for 8 to 12 weeks; always combined with topical therapy and strict sunscreen	Systemic adjunct (anti-fibrinolytic, anti-melanogenic)	Emerging evidence-based adjunct for moderate to severe or refractory melasma. Reduces melanocyte stimulation and dermal vascularization. Not appropriate for patients with personal or family history of blood clots, thromboembolic conditions, or those taking combination hormonal contraception. GI upset is the most common side effect. Avoid in pregnancy.
Broad-spectrum sunscreen SPF 50+ with iron oxide	Apply every morning and reapply every 2 hours outdoors; tinted formulations containing iron oxide are strongly preferred	Photoprotection (not a prescription medication)	The essential foundation of all melasma treatment. Iron oxide in tinted sunscreens blocks both UV and visible light (HEV), which is important for patients with skin types III through V. Without strict sun protection, topical lightening agents are significantly less effective and recurrence is rapid. Use year-round, even on cloudy days.

Important: Example regimens only. The actual medication, dosing, combination, and duration are individualized by the MD based on your melasma type, skin tone, Fitzpatrick type, prior treatment history, hormonal history, allergies, and relevant medical history. TeleDirectMD does not prescribe controlled substances.

Home Care, Sun Protection, and Follow-up

What to Do Now

Start strict sun protection immediately — apply broad-spectrum SPF 50+ sunscreen (preferably tinted with iron oxide) every morning before going outdoors, regardless of whether it is cloudy
Wear a wide-brimmed hat and seek shade during peak sun hours (10 AM to 4 PM), even while on treatment
If prescribed topical medication, apply it as directed — typically a thin layer to affected areas at night to reduce photosensitivity risk
Use a gentle, non-irritating cleanser and a non-comedogenic moisturizer; avoid harsh scrubs, exfoliants, or alcohol-based toners that can inflame the skin
Consider switching oral contraceptive pills to a non-hormonal method of contraception if the MD identifies hormonal use as a likely trigger — discuss this with your prescribing provider

What to Watch For During Treatment

Melasma treatment takes time — expect 8 to 24 weeks for meaningful visible improvement, and maintain realistic expectations throughout treatment
Mild skin irritation, redness, dryness, or peeling is common in the first few weeks of tretinoin or hydroquinone use and typically improves as your skin adjusts — do not stop treatment for mild irritation
If irritation is severe (painful redness, blistering, or significant swelling), stop the medication and contact your provider before continuing
Melasma commonly worsens with sun exposure even during treatment — any lapse in sun protection will slow progress significantly
If you notice any new raised, nodular, rapidly changing, or bleeding lesion, seek urgent in-person evaluation promptly — do not assume it is melasma

Follow-up Timing and Maintenance

Reassess your response to treatment at 8 to 12 weeks — if no improvement is visible with consistent use and strict sun protection, the regimen may need adjustment or dermatology referral
Melasma is chronic and relapsing — after initial improvement, a maintenance approach using topical agents and lifelong sun protection is typically needed to prevent recurrence
Plan for increased vigilance during summer months and any period of increased sun exposure, as melasma commonly flares seasonally
If you are using oral tranexamic acid, discuss the appropriate duration and whether a course extension or maintenance strategy is appropriate at your follow-up visit
If melasma does not respond to consistent topical and oral treatment, seek in-person dermatology evaluation to discuss procedural options such as chemical peels or laser therapy

When Not to Use TeleDirectMD for Melasma in Montana

TeleDirectMD is designed for typical adult melasma that is well-suited for visual telehealth assessment and topical prescription management. We are direct about when telehealth is not the right fit.

You Should Not Use TeleDirectMD If

You have a raised, nodular, or thickened pigmented lesion — melasma is always flat
You have a rapidly changing pigmented lesion (size, color, shape, or border changing over days to weeks)
You have a lesion with features suspicious for melanoma — asymmetry, irregular border, multiple colors, diameter greater than 6 mm, or evolving
You have new diffuse skin darkening with systemic symptoms such as fatigue, weight loss, or salt craving suggesting Addison's disease or another systemic condition
You are pregnant and need a new melasma treatment regimen — medication safety in pregnancy requires in-person counseling
You need procedural treatment for melasma such as chemical peels, laser therapy, intense pulsed light, or microneedling
Your melasma has failed multiple prior treatments and needs dermatology-level evaluation including dermoscopy or Wood lamp
You are under 18 years old
You are not physically in Montana at the time of visit

Alternative Care Options

Emergency room or urgent care: any rapidly changing, raised, or bleeding pigmented lesion that may suggest melanoma or another serious condition requiring urgent evaluation
Dermatology: refractory or severe melasma, procedural treatments (chemical peels, laser, microneedling), atypical presentations needing dermoscopy or biopsy, melasma in pregnancy, or any case failing standard topical and oral therapy
Primary care: suspected systemic cause of hyperpigmentation with associated symptoms needing laboratory evaluation, combined visit for other health concerns, or ongoing hormonal management
OB/GYN: melasma triggered by hormonal contraception where contraception change is being considered, or melasma in pregnancy requiring comprehensive obstetric and dermatologic coordination

Melasma Treatment FAQs for Montana

Can I get melasma treatment online in Montana?

Yes, if you are an adult 18+ located in Montana and your melasma is appropriate for telehealth after visual assessment. Melasma is a highly visual condition — its diagnosis is based on the appearance and distribution of flat pigmented patches, making telehealth an effective platform for evaluation and prescription management. TeleDirectMD can prescribe hydroquinone, tretinoin, azelaic acid, triple combination cream, and oral tranexamic acid when clinically appropriate. Presentations that are raised, rapidly changing, or otherwise concerning are directed to in-person evaluation.

How much does online melasma treatment cost in Montana?

TeleDirectMD offers a transparent self pay option starting at $49 for an adult video visit in Montana. Insurance is not required. Prescription costs at your pharmacy are separate and vary by medication and pharmacy.

Does Montana allow telemedicine for this kind of visit?

Yes. Montana allows licensed professionals to provide telemedicine within their scope when appropriate and according to accepted standards of care.

Can a doctor diagnose melasma without an in-person exam?

Yes, for typical melasma. Melasma has characteristic features — symmetric, flat brown to gray-brown patches on sun-exposed facial areas — that can be assessed visually during a video visit. The MD reviews your pigmentation pattern, trigger history, and prior treatment history. If the presentation is atypical, raised, rapidly changing, or uncertain, an in-person examination with dermoscopy or biopsy may be recommended.

What is the best treatment for melasma?

Current evidence supports a combination approach as most effective: strict broad-spectrum photoprotection (the essential foundation), topical hydroquinone 4%, and topical retinoids such as tretinoin. Triple combination cream (hydroquinone/tretinoin/fluocinolone — Tri-Luma) is the most effective single topical option in clinical trials. Oral tranexamic acid 250 mg twice daily is an effective emerging adjunct for moderate to severe cases. Without consistent sun protection — including an SPF 50+ tinted sunscreen with iron oxide — any topical treatment will have significantly limited efficacy and recurrence will be rapid.

How long does melasma treatment take to work?

Melasma treatment typically requires 8 to 24 weeks to show meaningful visible improvement. Tretinoin requires a minimum of 24 weeks for full effect. Oral tranexamic acid typically shows effect at 2 to 3 months. Consistency with both medication application and strict sun protection is essential. Melasma is a chronic condition — after initial improvement, ongoing maintenance therapy and lifelong sun protection are typically needed to prevent recurrence.

Does my birth control cause melasma?

Yes, hormonal contraception is a common trigger for melasma, occurring in 10 to 25 percent of women who take oral contraceptives. Hormones including estrogen and progesterone stimulate melanocyte activity. If your melasma worsened after starting hormonal contraception, discussing whether to switch to a non-hormonal method may be part of the management plan. TeleDirectMD can have this conversation during your visit, though changes to your contraceptive method should be coordinated with your OB/GYN or primary care provider.

Is melasma the same as the 'mask of pregnancy'?

Yes. 'Mask of pregnancy' (also called chloasma) is the same condition as melasma occurring during pregnancy. It affects 10 to 15 percent of pregnant women and typically presents as symmetric brown patches on the face. Pregnancy-induced melasma often fades naturally in the months after delivery, and treatment is typically deferred postpartum to allow spontaneous improvement. If it persists postpartum and you are not breastfeeding, telehealth treatment is often appropriate.

Can TeleDirectMD provide melasma care in other states?

Yes. TeleDirectMD offers adult evaluations via video visits across multiple states where our physicians are licensed. You must be physically located in the state where you are requesting care at the time of your video visit.

Can I use my insurance for a TeleDirectMD visit?

Insurance is not required. If your plan is eligible, you may be able to use insurance. A self pay option is also available.

When should I be worried that a dark spot is not melasma?

You should seek urgent in-person evaluation if a pigmented lesion is raised or nodular (melasma is always flat), is rapidly changing in size, color, shape, or border over days to weeks, has irregular or notched borders, bleeds spontaneously, or if you have new diffuse skin darkening with fatigue, weight loss, or other systemic symptoms. These features are not consistent with melasma and require in-person examination and possibly biopsy. TeleDirectMD will direct you to in-person care if any features during your video visit are concerning.

Does sunscreen really matter that much for melasma?

Yes — sunscreen is the single most important part of melasma management. UV and visible light exposure are the primary triggers for melasma, and without consistent daily photoprotection, topical treatments will have significantly limited efficacy and recurrence after treatment will be rapid. A broad-spectrum SPF 50+ sunscreen containing iron oxide (found in tinted formulations) is strongly recommended because iron oxide blocks both UV light and high-energy visible (blue) light, both of which can worsen melasma — particularly in Fitzpatrick skin types III through V.

Need help today?

Insurance is not required. Adult-only video visits. MD-only care. Visual melasma assessment, evidence-based prescriptions when appropriate, comprehensive sun protection counseling, and clear next steps.

Book a Visit View All Adult Conditions

References

TeleDirectMD Telehealth Disclaimer

TeleDirectMD provides MD-only virtual care for adults (18+) in Montana using secure video visits to evaluate melasma, provide evidence-based guidance, and prescribe topical lightening agents and other appropriate treatments when clinically appropriate. Insurance is not required. You must be physically located in Montana at the time of your video visit. TeleDirectMD does not prescribe controlled substances.

TeleDirectMD is not an emergency service and is not a replacement for in-person dermatology care when procedural treatments, biopsy, dermoscopy, or evaluation for melanoma or other serious pigmentary conditions is needed. Any raised, nodular, rapidly changing, or otherwise suspicious pigmented lesion requires urgent in-person evaluation and should not be assessed by telehealth alone. This service is intended for typical, clinically consistent melasma and is not appropriate for management of suspected melanoma or other skin cancers.

Online melasma treatment in Montana. Melasma prescription online. Hyperpigmentation treatment by video visit. Hydroquinone prescription online Montana. Melasma doctor online.

Get Melasma Treatment Treatment in Other States

TeleDirectMD treats melasma treatment via telehealth in 41 states. If you are traveling, relocating, or helping a family member in another state, select below to find this treatment near them.